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Abstract
Background: Tissue-engineered scaffold should mimic the structure and biological function of the extracellular
matrix and have mechanically supportive properties for tissue regeneration. In this study, we utilized a PLGA/PLA
mesh scaffold, coated with cell-derived extracellular matrix (CDM) and assessed its potential as an osteogenic
microenvironment for human umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs). CDM was
obtained by decellularization of in vitro-cultured type I collagen overexpressing (Col I -293 T-DK) cells. Test groups
are mesh itself (control), fibronectin-coated (FN-mesh), and CDM-coated mesh scaffold (CDM-mesh). CDM was then
solubilized and used for scaffold coating.
Results: CDM was successfully collected and applied to mesh scaffolds. The presence of CDM was confirmed via
SEM and FN immunofluorescence. After then, UCB-MSCs were seeded into the scaffolds and subjected to the
induction of osteogenic differentiation for 21 days in vitro. We found that the seeded cells were viable and have
better proliferation activity on CDM-mesh scaffold. In addition, when osteogenic differentiation of UCB-MSCs was
examined for up to 21 days, alkaline phosphatase (ALP) activity and osteogenic marker (COL I, ALP, osteocalcin,
bone sialoprotein) expression were significantly improved with UCB-MSCs when cultured in the CDM-mesh scaffold
compared to the control and FN-mesh.
Conclusion: Polymer mesh scaffold incorporated with CDM can provide UCB-MSCs with a better
microenvironment for osteogenesis in vitro.
Keywords: Osteogenesis, Cell-derived extracellular matrix (CDM), Polymer mesh scaffold, Umbilical cord blood-
derived mesenchymal stem cells (UCB-MSCs), Microenvironment
Background
Bone tissue engineering has an ultimate goal to regenerate
damaged or lost bone tissue via osteoconductive and/or
osteoinductive scaffolds [1]. The 3D polymer scaffolds is
supposed to provide appropriate microenvironments to
support stem cells adhesion, growth and differentiation,
making them suitable for a new bone formation [2]. To do
this, polymer scaffolds have been combined with biomate-
rials derived from natural sources. Examples are collagen
[3], gelatin [4], fibrin [5], silk fibroin, keratin [6], and
others [7]. In addition, extracellular matrix (ECM) is a
complex network of a variety of proteins, proteoglycans,
and other macromolecules, where it can provide structural
and biochemical support to the surrounding cells [8, 9]. It
is well recognized that ECM microenvironments are crit-
ical to support cell adhesion, migration, proliferation, and
differentiation [10]. Therefore, many studies have also uti-
lized ECM as a valuable resource in tissue engineering
[11]. Specifically, ECM obtained from in vitro cultured
cells has been studied as a source of bone tissue engineer-
ing [12, 13]. Cell-derived extracellular matrix (CDM) pro-
motes osteogenic differentiation of preosteoblasts and
bone marrow mesenchymal stromal cells, respectively
[14]. In addition CDMs are obtained from various cell
types and their positive effects are investigated on the
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multi-lineage differentiation of human mesenchymal stro-
mal cells [15].
However few studies have examined the effect of cell-
derived ECM in combination with an engineered 3D
scaffold. From this perspective, we have developed a new
platform, composed of a biodegradable PLGA/PLA mesh
scaffold, functionalized with bioactive CDM derived
from type I collagen overexpressing (Col I -293 T-DK)
cells. Our hypothesis is that CDM coated polymer mesh
scaffold can represent 3D microenvironment suitable for
MSCs adhesion, proliferation, and osteogenic differenti-
ation. In this work, we selected umbilical cord blood-
derived mesenchymal stem cells (UCB-MSCs) as a MSCs
source. Like other MSCs, UCB-MSCs possess a high prolif-
eration rate for in vitro expansion and have multi-potency
capable of differentiating into osteogenic, chondrogenic,
and adipogenic lineage [16, 17]. In our study, we found out
a significant improvement of osteogenesis of UCB-MSCs
on CDM-treated mesh scaffold.
Methods
Preparation of PLGA/PLA mesh scaffolds
Poly (L-lactide-co-glycolide) (PLGA; lactic to glycolic
acid molar ratio, 50:50) and poly (L-lactide) (PLA) was
purchased from EVONIK. PLGA and PLA fibers, 2–
2.5 mm in length, were prepared by using a rotary cut-
ter and their nonwovens were produced via modified
wet-laid process. PLGA and PLA fibers were mixed in
an aqueous solution with a dispersing agent (1 wt.%
Pluronic F127; Sigma-Aldrich) and randomly laid on a
wire mesh to filter the liquid. The formed web was sub-
sequently processed through a thermal bonding, in which
the web was transferred to a heater and cured at 170 °C for
5 min. The resulting mesh was cut into sheets (4 × 4 × 4
mm, L ×W×H) and they were sterilized by soaking in
100 % ethanol under ultraviolet (UV) light.
Cell-derived matrix (CDM) preparation
Collagen type I-overexpression cell line (Col I-293 T-
DK) was cultured at the density of 1.3 × 104 cells/cm2
in a 100 mm diameter petri-dish for 4 days in the
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10 % fetal bovine serum (FBS) and 100
U/mL penicillin and 100 μg/mL streptomycin (P/S).
At the time of confluence, the cell culture plates were
washed twice with phosphate buffered saline (PBS),
incubated briefly in a detergent solution containing
0.25 % Triton X-100 and 10 mM NH4OH (Sigma-Aldrich)
at 37 °C, and then subjected to the treatment of 50 U/mL
DNase I and 2.5 μL/mL RNase A (Invitrogen) for 1 h at
37 °C. After the decellularization process, the specimens
were washed with PBS thoroughly and stored at 4 °C
before use.
CDM characterization: protein and DNA content
For CDM analysis, DNA was examined from the organic
phase using Trizol® reagent (Invitrogen). 0.3 mL of 100 %
EtOH was added to isolate the DNA from each sample and
after centrifugation the supernatant was collected. The
supernatant was washed twice with 0.1 M sodium citrate in
10 % EtOH, then centrifuged at 2000 g for 5 min at 4 °C.
The samples were resuspended in 2 mL of 75 % ethanol
and centrifuged again. The pellets were dissolved in 300 μL
of 8 mM NaOH and subsequently quantified using a Nano-
Drop ND 1000 Spectrophotometer (Thermo Fisher Scien-
tific). In addition, BCA protein assay kit (23250, Thermo
Scientific) was used according to the manufacturer’s in-
structions to assess the total protein amount of CDM.
Preparation of CDM-coated mesh scaffolds
After the decellularization, CDM was harvested by gentle
pipetting, transferred to 50 mL tubes, and vigorously agi-
tated using a homogenizer (HG-3000, SMT, Japan) until a
homogeneous aqueous phase was formed. The polymer
mesh scaffolds were then immersed into the CDM sus-
pension solution with a mild agitation and incubated for
24 h. The CDM-coated mesh scaffolds were then freeze-
dried overnight. Fibronectin (FN; BD Biosciences)-coated
mesh scaffolds were also prepared by soaking the scaffolds
in FN solution (50 μg/mL in distilled water) at 37 °C for
1 h. The FN-coated scaffolds were then rinsed with dis-
tilled water and freeze-dried. The surface morphology of
the FN- and CDM-coated mesh scaffolds was observed
via scanning electron microscopy (SEM; Phenom G2 Pro
Desktop). In addition, the distribution of the CDM in the
mesh scaffolds was visualized via immunofluorescence
staining of fibronectin using mouse monoclonal antibody
(SC-8422; Santa Cruz Biotechnology) and Alex Fluor 488-
conjugated secondary antibody (goat anti-mouse IgG;
Invitrogen), respectively.
In vitro culture of UCB-MSCs and proliferation assay
Human umbilical cord blood mesenchymal stem cells
(UCB-MSCs) were kindly provided by MEDIPOST Co
(Seoul, Korea). UCB-MSCs were cultured in Minimum
Essential Medium alpha medium (α-MEM) supplemented
with 10 FBS and 1 % P/S. Cells were seeded at 5 × 105 cells
in culture flasks and maintained at 37 °C in a humidified
5 % CO2 atmosphere with a medium change twice a week.
Passage 9 UCB-MSCs were used throughout the experi-
ments. Mesh scaffolds were transferred into non-adherent
24-well tissue culture plates, onto which UCB-MSCs were
slowly inoculated at a density of 5 × 104 cells per scaffold.
Cells were allowed to adhere for 3 h and cultured in a
growth medium for up to 5 days. Three different test
groups (n = 3, per group) were prepared: 1) plain mesh
(control), 2) fibronectin-coated mesh (FN-mesh), and 3)
CDM-coated mesh (CDM-mesh). Cell proliferation was
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evaluated on 2nd and 5th day of culture using CCK-8 assay
(Dojindo, Japan). Aliquots from each sample (100 μL)
were transferred into a 96-well plate and measured for the
absorbance at a wavelength of 450 nm using a Multiskan
microplate reader (Thermo Scientific).
Osteogenic differentiation of UCB-MSCs
Osteogenic differentiation of UCB-MSCs was induced
in the presence of osteogenic supplements such as
10 % FBS, 1 % P/S, 50 μg/mL ascorbic acid, 0.01 M
glycerol-2-phosphate, 50 ng/mL bone morphogenetic
protein (BMP)-2 and 100 nM dexamethasone for 1
and 3 weeks, respectively. Medium was changed every
2 or 3 day.
Alkaline phosphatase (ALP) activity
ALP activity of each group (n = 4 per group) after osteo-
genic induction for 3 weeks was analyzed using a Lab
Assay ALP kit (Wako Pure Chemicals, Japan). Samples
were incubated in the lysis buffer (0.1 % Triton X-100 in
PBS) for 30 min at 37 °C. 50 mL of the lysis solution was
added to 2 mg/mL of p-nitrophenyl phosphate (Sigma 104
tablet) in 0.1 M Tris–HCl buffer (pH 8.5). The absorbance
was measured at 405 nm and normalized to the total
amount of proteins in each sample lysate, which was
assessed via BCA assay (Thermo Scientific).
Quantitative real-time polymerase chain reaction (q-PCR)
Gene expression of osteogenic markers, such as bone
sialoprotein (BSP), collagen type I (Col I), ALP, and
osteocalcin (OC) was analyzed via quantitative real-
time PCR. Total RNA was isolated using a Trizol®
reagent (Invitrogen) extraction method. The extracted
samples were subsequently quantified using a Nano-
Drop ND1000 Spectrophotometer (Thermo Fisher
Scientific). cDNA synthesis was performed using a
Maxime RT premix kit (Intron). All polymerase chain
reactions were carried out using ABI Prism 7500 (Applied
Biosystems) and gene expression level was quantified
using SYBR Green (RR420A, TaKaRa). Relative gene ex-
pression level was calculated by the delta delta Ct method.
The primer sequences of the target genes are as follows
BSP: CAACCACCCTCTTCACCACT (forward) and GA
TCTTCTGGGGTGGTCTCA (reverse); ALP: ATGGGA
TGGGTGTT CCTACA (forward) and GTCTTAGAGA
GGGCGACGTG (reverse); Col I: CAAGAACCC CAAG
GACAAGA (forward) and GAATCCATCGGTCATG
CTCT (reverse); OC: CCAGTT CTGCTCCTCTCCAG
(forward) and GCCCACAGATTCCTCTTCTG (reverse)
Housekeeping gene is glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH): GGGCTCTCCAGAACATCATC
(forward) and TTCTAGACGGCAGGTCAGGT (reverse).
Histological analysis
Harvested samples at 1 and 3 weeks were fixed in 4 %
paraformaldehyde for 24 h, dehydrated, embedded in
paraffin wax, and cut into 10 μm thickness. Those thin
sections (n = 4 per group) were then subjected to
Alizarin Red, ALP and von kossa staining, respectively.
Statistical analysis
Data are expressed as mean ± standard deviation. Statis-
tical significance is determined via one-way analysis of
variance (ANOVA) with a posthoc, Bonferroni’s multiple
comparison test (GraphPad Prism 5, La Jolla, CA). Stat-
istical significance is marked as * (p < 0.05), ** (p < 0.01),
or *** (p < 0.001).
Results & discussion
Characterization of CDM
A confluent cell layer of Col I-293 T-DK cell line on
petri-dish was observed under phase contrast micro-
scope (Fig. 1a, top). After decellularization, it was clear
that the original cellular morphology were completely
removed (Fig. 1a, bottom). The resulting extracellular
matrix (ECM) layer is named cell-derived extracellular
matrix (CDM). This decellularization procedure is sup-
posed to get rid of cellular components, specifically nu-
cleic and cytosolic ones while retaining bioactive
extracellular compositions [18, 19]. Total protein con-
tent and DNA amount before and after decellularization
were examined, respectively and compared with each
other. BCA assay found out that total protein amount of
CDM is 1918 μg/per dish, and there is little difference
compared to that before decellularization (1996 μg)
(Fig. 1b). In addition, it was obvious that cellular DNA
was almost completely removed by current decellulariza-
tion; the amount of DNA (1.5 ng DNA/mg) in CDM
was less than 2 % that of the cells (88.61 ng DNA/mg)
before decellularization (Fig. 1c). Current DNA amount
seems to be negligible, based on the report by Crapo
and Gilbert; less than 50 ng of double stranded DNA
Fig. 1 Preparation of CDM and characterization. a Cell morphology
before decellularization (top) and after decellularization (bottom). b
Total protein amount before and after decellularization was
quantified by BCA assay. c DNA content of CDM was also compared
before and after decellularization. The scale bar is 200 μm
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per mg of ECM should be a minimum criteria regarding
the procedure of decellularization [20]. These results
demonstrate that our decellularization procedure is ef-
fective in clearing cellular DNA while preserving the
extracellular macromolecules to a large extent.
Surface analysis of CDM-coated mesh scaffold
To confirm whether CDM is successfully coated on the
mesh scaffolds, they were examined using SEM and im-
munofluorescence staining against FN. The SEM images
of mesh scaffold without coating exhibited smooth and
randomly aligned fibers whereas both CDM-coated and
FN-coated group showed the presence of coating mater-
ial on the microfibers (Fig. 2); FN-coated one shows a
thin layer of matrix coating on the microfibers whereas
CDM-coated one holds more abundant matrix moieties
in the mesh fibers. More specifically, the ECM on the
CDM-coated mesh adheres to the microfibers and it also
occupies the interstices in the mesh scaffold, contrasted
o the ECM on the FN-mesh scaffold. The presence of
ECM on mesh scaffold is further confirmed by FN im-
munostaining, as FN is one of the most important com-
ponents of CDM [21]. Mesh scaffold alone shows no
positive signals of FN. Compared to the FN-coated
microfiber, CDM-coated one exhibited much better FN
positive signals that homogeneously distributed through
mesh scaffold (Fig. 2, Inset). Current data demonstrate
that CDM coating is effective and rather homogeneous
through the mesh scaffold.
UCB-MSCs viability and proliferation
To evaluate the capacity of the CDM-coated mesh scaf-
folds for cell attachment and growth, we cultured UCB-
MSCs and examined cell viability via Live & Dead stain-
ing after 2 days post-seeding. Representative images of
UCB-MSCs exhibited that they are well attached to both
CDM- and FN-coated mesh scaffold and the cells are vi-
able (stained in green) in these scaffolds (Fig. 3a). As the
proliferation of UCB-MSCs is further examined for up
to 5 days via CCK-8 assay, the cell number continuously
increased with time on all the mesh scaffolds. However,
CDM-mesh was a significantly better on UCB-MSCs
proliferation than FN-mesh and plain mesh (Fig. 3b). It
can be explained that, comprised of various ECM mac-
romolecules [22, 23], CDM not only provides abundant
cell-binding motifs but also plays a certain role in pro-
moting cell proliferation [22].
ALP activity and gene expression of osteogenic markers
The effect of CDM-coated mesh scaffolds in facilitating
MSCs differentiation is examined by culturing UCB-
MSCs in osteogenic medium for 1 and 3 weeks, respect-
ively. When the samples were subjected to ALP staining
at 3 weeks, CDM-coated mesh was much more positive
in ALP activity (Fig. 4a). Although ALP activity in-
creased with time for all the groups, a significantly
higher level of ALP activity was observed at both 1 and
3 weeks from the cells cultured on the CDM-coated
mesh than those cultured on FN-mesh or control
(Fig. 4b). To further examine UCB-MSCs osteogenic dif-
ferentiation in gene level, Col I, ALP, OC, and BSP are
used as osteogenic markers (Fig. 5). Expression levels of
both ALP and BSP are relatively higher at 1 week in FN-
mesh and CDM-mesh group compared to that of plain
mesh. However, the expression level of BSP and ALP
was significantly up-regulated at 3 weeks only in CDM-
mesh, more than 3-fold greater than that of the other
two groups. Similarly, the expression of Col I and OC
was also up-regulated in the CDM-coated mesh with
time. These results indicate that CDM can promote
UCB-MSCs osteogenic differentiation in 3D environ-
ment and are better than FN.
Histological analysis
Osteogenic differentiation of UCB-MSCs on various mesh
scaffolds was also analyzed by Alizarin red and von kossa
staining, respectively. While Alizarin red staining exhib-
ited a sign of calcium deposition (red color) in the CDM-
Fig. 2 Surface characterization of mesh scaffolds. The surface
morphology of differently treated mesh scaffolds (control, FN-coated,
and CDM-coated) is observed via SEM. The scale bar is 500 μm. Insets
exhibit the distribution of fibronectin (green) in the mesh scaffolds. The
scale bar is 200 μm
Fig. 3 UCB-MSCs viability and proliferation in the mesh scaffold. a The
viability of UCB-MSCs cultured on various mesh scaffolds was examined
via Live & Dead staining at 2 day. The scale is 200 μm. b UCB-MSCs
proliferation cultured on control, FN-coated, and CDM-coated mesh
scaffold is measured at 2 and 5 day, respectively via CCK-8 assay (n = 3;
**p < 0.01, ***p < 0.001)
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mesh, both FN-mesh and control presented few positive
signals (Fig. 6a). Von kossa staining also confirms much
better calcium accumulation (black color) with the CDM-
mesh, and some positive signals were found on the FN-
mesh at 3 week (Fig. 6b). Insets exhibit the corresponding
staining of each group at 1 week.
Conclusions
In this study, CDM obtained from in vitro cultured Col
I-overexpression cells was collected and successfully
coated onto 3D mesh scaffold. CDM provides a much
better microenvironment for UCB-MSCs adhesion and
proliferation than FN. More importantly, CDM-coated
Fig. 4 Alkaline phosphatase (ALP) staining and ALP activity measurement. a UCB-MSCs cultured in osteogenic medium for 3 weeks were subjected to
ALP staining. Insets show the background staining. The scale is 200 μm. b When the ALP activity of UCB-MSCs is also measured, that of CDM-coated
mesh scaffold is significantly higher than the other groups at 3 week (*p < 0.05, **p < 0.01, ***p < 0.001)
Fig. 5 Q-PCR analysis of osteogenic gene expression. Gene expression of BSP, Col I, ALP, and OC was examined via Q-PCR after 1 and 3 weeks of
culture in the mesh scaffolds. Gene expression levels of FN and CDM-mesh group were normalized to that of the control (plain mesh) (*p < 0.05,
**p < 0.01, ***p < 0.001)
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mesh scaffold supports UCB-MSCs osteogenic differenti-
ation, much better than FN-coated one as indicated by
protein and gene expression as well as by histological
staining. However, the related cellular and molecular
mechanism behind how CDM up-regulates the osteogenic
differentiation of UCB-MSCs warrants further investiga-
tion. In summary, combination of CDM and polymer
mesh scaffold can produce a biomimetic 3D microenvir-
onment and make it a suitable platform for further investi-
gation of stem cell culture and differentiation.
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